robert hasserjian, md, on why the icc introduced an mds, aml overlap group
Published 1 year ago • 227 plays • Length 5:02Download video MP4
Download video MP3
Similar videos
-
3:03
what are clinical trials and why are they key to modern healthcare?
-
0:44
heart disease risk factors
-
41:14
cancer is a metabolic disease: a new paradigm with dr. seyfried (episode 2)
-
28:44
6. the burden of aml - mutations and prognostic implications, dr. naval daver
-
1:41
dr. larry goldstein reflects on his research and experiences at isc throughout the years
-
1:15:57
the lie of america's war on cancer
-
58:23
if researchers find a tumor should they tell you? - exploring ethics
-
36:00
hematology | types of anemias
-
1:07
why would you see a hematologist oncologist?
-
1:35
artificial intelligence revolutionizes diagnosis in one of the world s deadliest cancers
-
2:30
high stakes of diagnosis
-
0:48
what is chemo brain? (explained by dr. denson, md hematology & oncology)
-
12:53
the war on cancer: from nixon until now | retro report | the new york times
-
0:59
kenneth shain, md, phd - malignant hematology
-
2:49
research in the cancer and blood diseases institute
-
1:34
australasian lymphoma alliance consensus practice statement on the diagnosis and management of fl
-
1:26
cancer: why a doctor will refer their patient? - dr michael osborn oncologist & haematologist
-
19:18
understanding covid-19, part 1: recognizing a new disease
-
2:53
meet ben heyman, md: hematologist
-
21:37
hbcf 2022 - professor stephen ackland, medical oncologist